Physician profile
Jeffrey Lee
NPI 1194221325
$954.16
in general payments reported to CMS, 2019-2025
7 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $528 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $273.29 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $249.89 | 2023-2024 | Lynparza |
| Teleflex LLC | $158.90 | 2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $137.32 | 2024 | Advantage System |
| Endo USA, INC. | $75.98 | 2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $32.66 | 2025 | Xyosted |
| Tolmar, INC. | $26.12 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.